Sedana Medical AB (publ)

OM:SEDANA Stock Report

Market Cap: SEK 1.6b

Sedana Medical Management

Management criteria checks 1/4

Sedana Medical's CEO is Johannes Doll, appointed in Oct 2021, has a tenure of 3.25 years. total yearly compensation is SEK5.24M, comprised of 62.2% salary and 37.8% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth SEK1.90M. The average tenure of the management team and the board of directors is 2.8 years and 2.7 years respectively.

Key information

Johannes Doll

Chief executive officer

SEK 5.2m

Total compensation

CEO salary percentage62.2%
CEO tenure3.3yrs
CEO ownership0.1%
Management average tenure2.8yrs
Board average tenure2.7yrs

Recent management updates

Recent updates

There's Reason For Concern Over Sedana Medical AB (publ)'s (STO:SEDANA) Massive 26% Price Jump

Dec 12
There's Reason For Concern Over Sedana Medical AB (publ)'s (STO:SEDANA) Massive 26% Price Jump

kr34.00: That's What Analysts Think Sedana Medical AB (publ) (STO:SEDANA) Is Worth After Its Latest Results

Oct 28
kr34.00: That's What Analysts Think Sedana Medical AB (publ) (STO:SEDANA) Is Worth After Its Latest Results

Sedana Medical AB (publ)'s (STO:SEDANA) 36% Cheaper Price Remains In Tune With Revenues

Oct 25
Sedana Medical AB (publ)'s (STO:SEDANA) 36% Cheaper Price Remains In Tune With Revenues

After Leaping 27% Sedana Medical AB (publ) (STO:SEDANA) Shares Are Not Flying Under The Radar

Jun 07
After Leaping 27% Sedana Medical AB (publ) (STO:SEDANA) Shares Are Not Flying Under The Radar

Sedana Medical AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Apr 28
Sedana Medical AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation

Mar 16
Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation

Optimistic Investors Push Sedana Medical AB (publ) (STO:SEDANA) Shares Up 34% But Growth Is Lacking

Dec 21
Optimistic Investors Push Sedana Medical AB (publ) (STO:SEDANA) Shares Up 34% But Growth Is Lacking

We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely

Oct 29
We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely

Sedana Medical (STO:SEDANA) Is In A Good Position To Deliver On Growth Plans

Jul 12
Sedana Medical (STO:SEDANA) Is In A Good Position To Deliver On Growth Plans

Analysts Just Made A Major Revision To Their Sedana Medical AB (publ) (STO:SEDANA) Revenue Forecasts

May 01
Analysts Just Made A Major Revision To Their Sedana Medical AB (publ) (STO:SEDANA) Revenue Forecasts

We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely

Feb 17
We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely

Analysts Are More Bearish On Sedana Medical AB (publ) (STO:SEDANA) Than They Used To Be

Jan 20
Analysts Are More Bearish On Sedana Medical AB (publ) (STO:SEDANA) Than They Used To Be

Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation

Oct 05
Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation

Companies Like Sedana Medical (STO:SEDANA) Are In A Position To Invest In Growth

Jul 05
Companies Like Sedana Medical (STO:SEDANA) Are In A Position To Invest In Growth

Sedana Medical AB (publ) (STO:SEDANA) Analysts Just Slashed This Year's Estimates

May 03
Sedana Medical AB (publ) (STO:SEDANA) Analysts Just Slashed This Year's Estimates

CEO Compensation Analysis

How has Johannes Doll's remuneration changed compared to Sedana Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 57m

Jun 30 2024n/an/a

-SEK 41m

Mar 31 2024n/an/a

-SEK 23m

Dec 31 2023SEK 5mSEK 3m

-SEK 60m

Sep 30 2023n/an/a

-SEK 57m

Jun 30 2023n/an/a

-SEK 58m

Mar 31 2023n/an/a

-SEK 71m

Dec 31 2022SEK 5mSEK 3m

-SEK 74m

Sep 30 2022n/an/a

-SEK 54m

Jun 30 2022n/an/a

-SEK 62m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 5mSEK 1m

-SEK 58m

Compensation vs Market: Johannes's total compensation ($USD468.50K) is above average for companies of similar size in the Swedish market ($USD226.78K).

Compensation vs Earnings: Johannes's compensation has increased whilst the company is unprofitable.

CEO

Johannes Doll (43 yo)

3.3yrs

Tenure

SEK 5,244,000

Compensation

Mr. Johannes Doll serves as Chief Executive Officer and President at Sedana Medical AB (publ) since October 01, 2021. Mr. Doll had been Executive Vice President and Chief Commercial Officer at Orexo AB (pu...

Leadership Team

NamePositionTenureCompensationOwnership
Johannes Doll
CEO & President3.3yrsSEK 5.24m0.12%
SEK 1.9m
Johan Spetz
Chief Financial Officer2.8yrsno data0.12%
SEK 1.9m
Karolina Vilval
General Counsel2.4yrsno datano data
Peter Sackey
Chief Medical Officer7yrsno data0.24%
SEK 3.8m
Linda Frölén
Head of Group Financeno datano datano data
Anders Ersson
Head of International Markets2.6yrsno datano data
Clarisa Mogollón
Chief Commercial Officer1.1yrsno datano data
Jessica Westfal
VP of Regulatory Affairs and QA4.7yrsno data0.0057%
SEK 91.8k
Uwe Veismann
GM for Germany1.5yrsno datano data
Stefan Krisch
Supply Chain & Manufacturing Director3.8yrsno data0.028%
SEK 444.8k

2.8yrs

Average Tenure

47yo

Average Age

Experienced Management: SEDANA's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Claus Bjerre
Independent Chairman of the Board3.7yrsSEK 545.00k0.25%
SEK 3.9m
Donna Haire
Directorless than a yearno datano data
Jens Viebke
Independent Directorless than a yearno datano data
Hilde Furberg
Independent Director2.7yrsSEK 242.00kno data
Christoffer Rosenblad
Independent Director4.7yrsSEK 317.00k0.010%
SEK 161.3k

2.7yrs

Average Tenure

55yo

Average Age

Experienced Board: SEDANA's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/18 02:34
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sedana Medical AB (publ) is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter ÖstlingPareto Securities
Filip WibergPareto Securities
Oscar BergmanRedeye